Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: Study of Chokeberry to Reduce Cardiovascular Disease Risk in Former Smokers [NA]

View source ↗

Summary

The study evaluating chokeberry to reduce cardiovascular disease risk in former smokers has completed, and the results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chokeberry extract supplement (Aronia berry extract)

Snippet

Sponsor: University of Connecticut | Conditions: Cardiovascular Disease, Oxidative Stress | NA | Status: COMPLETED | Results posted: 2017-07-11